• 1
    Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC, Medsger TA Jr, Felts WR, Shulman LE: Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 16: 427441, 1989
  • 2
    Ehrlich GE: Inflammatory arthritis: the clinical syndrome. J Chronic Dis 25: 317328, 1972
  • 3
    Myers SL, Brandt KD, Ehlich JW, Braunstein EM, Shelbourne KD, Heck DA, Kalasikini LA: Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol 17: 16621669, 1990
  • 4
    Somerville KW, Faulkner G, Langman MJS: Non steroidal antiinflammatory drugs and bleeding gastric ulcer. Lancet 1: 462464, 1986
  • 5
    Fries JF, Williams CA, Bloch DA: The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum 34: 13531360, 1991
  • 6
    Loose LD, de Oliveira R, Sipe JD, Franzblau C, Shanahan WR: A possible systemic component of osteoarthritis: elevated concentrations (by ELISA) of C-reactive protein in serum of OA patients and modulation by tenidap (abstract). Arthritis Rheum 36 (Suppl 9): S166, 1993
  • 7
    Hart DJ, Spector TD: The relationship of obesity, fat distribution and osteoarthritis in the general population: The Chingford Study. J Rheumatol 20: 331335, 1993
  • 8
    Kellgren JH, Lawrence JS: The epidemiology of chronic rheumatism. In, Atlas of Standard Radiographs. Vol. 2. Oxford, Blackwell Scientific, 1963
  • 9
    Burnett S, Hart DJ, Cooper C, Spector TD: A Radiographic Atlas of Osteoarthritis. London, Springer-Verlag, 1994
  • 10
    WHO Expert Committee on Biological Standardization: Thirty-Seventh Report. Geneva, WHO Technical Report Series 760, 1987
  • 11
    Sipe JD: Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 25: 7586, 1995
  • 12
    Acheson RM, Collart AB: New Haven survey of joint diseases: relationship between some systemic characteristics and osteoarthritis in a general population. Ann Rheum Dis 34: 379387, 1975
  • 13
    Spector TD, Hart DJ, Byrne J, Harris P, Dacre JE, Doyle DV: Definition of osteoarthritis of the knee for epidemiologic studies. Ann Rheum Dis 52: 790794, 1993
  • 14
    Hart DJ, Nandra D, Spector TD: Assessing joint space in progression of early osteoarthritis: a comparison of magnified reticule and atlas grades (abstract). Arthritis Rheum 38 (Suppl 9): S239, 1995
  • 15
    Sharif M, George E, Shepstone GL, Knudson W, Thonar EJ-MA, Cushnoghan J, Dieppe P: Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38: 760767, 1995
  • 16
    Brandt KD: A pessimistic view of serologic markers for diagnosis and management of osteoarthritis: biochemical, and immunologic, and clinico-pathologic barriers. J Rheumatol 18 (Suppl): 3942, 1989
  • 17
    Lohmander LS: Molecular markers to monitor outcome and intervention in osteoarthritis (promises, promises). Br J Rheumatol 34: 599601, 1995
  • 18
    Ledingham J, Regan M, Jones A, Doherty M: Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis 54: 5358, 1995
  • 19
    Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reactive protein and serum Amyloid A protein in severe unstable angina. New Engl J Med 331: 417424, 1994
  • 20
    Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 332: 635641, 1995